Close
Show

Drug Research

This Drug Research section covers latest in Pharma drug research updates & Pharmaceutical drug research news & Pharma industry research and developments.

Benzodiazepine Drugs Market Set to Record US$ 2.6 Bn by 2026; the U.S. to Remain Attractive Market

Benzodiazepine Drugs Market Set to Record US$ 2.6 Bn by 2026; the U.S. to...


The U.S. is expected to account for around one-third of the total share in the...
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus

Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus


Regeneron  announced an expanded agreement with the U.S. Department of Health and Human Services (HHS)...
Aimmune secures $200m funding from Nestle Health Science

Aimmune secures $200m funding from Nestle Health Science


Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening...
Grey Wolf completes £2.5m Series A2 financing for development of therapies targeting ERAP2

Grey Wolf completes £2.5m Series A2 financing for development of therapies targeting ERAP2


Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology...

New Velesco Pharma clinical manufacturing facility begins operations


Pharmaceutical development expert, Velesco Pharma, is initiating operations at its new state-of-the-art cGMP clinical manufacturing...
Eisai's DAYVIGO gets approval in Japan to treat insomnia

Eisai’s DAYVIGO gets approval in Japan to treat insomnia


Eisai Co., Ltd. announced that it has obtained the manufacturing and marketing approval in Japan...

Eisai Commences Joint Research and Development of Cancer Gene Panel Test With Personal Genome...


Eisai Co., Ltd. announced that it has entered into a joint research and development agreement...
Medigene, IRICoR and Universite de Montreal sign collaboration and exclusive licensing option on novel cancer antigens

Medigene, IRICoR and Universite de Montreal sign collaboration and exclusive licensing option on novel...


Medigene AG , a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies,...

Predictive Oncology Acquire Quantitative Medicine and an AI Engine that Facilitates Accelerated Drug Discovery...


Predictive Oncology Inc , a knowledge-driven company focused on applying artificial intelligence to personalized medicine...

FDF China to be held in June to boost Chinese pharmaceutical enterprises to “go...


FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai...